Rob Dillard

Robert Dillard is the Senior Managing Editor of DocWire News, in charge of the platform’s day-to-day operations. He possesses 10 years of experience writing in the medical space, and has a passion for producing compelling, newsworthy content.

Articles by Rob Dillard

Rob DillardBreast Cancer | July 18, 2024
Adolescents and young adults of color who are BC survivors face a higher risk of long-term bone marrow suppression.
Read More
Rob DillardBreast Cancer | July 2, 2024
In the United States, nation of origin is significantly associated with breast cancer outcomes among Hispanic patients.
Rob DillardBreast Cancer | July 2, 2024
A study analyzed the association between discrimination, trust, and pain among Black women with early-stage BC.
Rob DillardBreast Cancer | June 17, 2024
Neighborhood deprivation is associated with increased BC mortality among non-Hispanic White women, but not Black women.
Rob DillardBreast Cancer | June 3, 2024
Black women experience higher obesity and breast cancer mortality rates than non-Black women.
Rob DillardBreast Cancer | May 31, 2024
Breast cancer diagnosis or treatment caused a moderate to great deal of change to sexual health in 89.5% of respondents.
Rob DillardASCO 2024 | May 30, 2024
Stage IV melanoma at presentation decreased from 2010 to 2020 in states with Medicaid expansion.
Rob DillardBreast Cancer | May 21, 2024
Racialized economic segregation is a social determinant of health in metastatic breast cancer.
Rob DillardBreast Cancer | April 15, 2024
A study assessed the impact of the COVID-19 pandemic on Black and Hispanic breast cancer (BC) survivors.
Rob DillardBreast Cancer | April 1, 2024
Support interventions are needed for managing oral endocrine therapy-related symptoms among Black breast cancer survivors.
Rob DillardBreast Cancer | March 28, 2024
Racial disparities exist in the initiation of chemotherapy, with a negative impact on Black women.
Rob DillardBreast Cancer | March 15, 2024
A study found racial disparities exist in breast cancer imaging therapy.
Rob DillardBreast Cancer | February 28, 2024
Factors such as a systemic mistrust of the health care system may prevent Black women from enrolling in trials for BC.
Rob DillardBreast Cancer | February 28, 2024
Pathologic complete response to neoadjuvant chemotherapy for TNBC and overall survival differ based on race/ethnicity.
Rob DillardBreast Cancer | February 21, 2024
Adding a polygenic risk score is effective at predicting breast cancer risk in Black women.
Rob DillardBreast Cancer | February 21, 2024
Analyzing somatic mutations in Latin American breast cancer patients may play a critical role in treatment planning.
Rob DillardBreast Cancer | February 13, 2024
The breast cancer recurrence score for recommending adjuvant chemotherapy may be less accurate for Black women.
Rob DillardBreast Cancer | February 13, 2024
The strong Black woman stereotype is detrimental to the well-being of Black patients with breast and ovarian cancers.
Rob DillardBreast Cancer | February 6, 2024
Using personal care products like nail polish during puberty may be associated with an increased risk of breast cancer.
Rob DillardBreast Cancer | February 6, 2024
Black populations have a significantly lower rate of breast cancer mortality decline compared with White populations.